menu
    • menu

    Company profile for Ipsen

    NEW Drugs in Dev: 46
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The Ipsen group is an independent French pharmaceutical laboratory. Historically based on the Dreux (Eure) manufacturing site since 1929, the Ipsen group has its head office located in Boulogne-Billancourt (Hauts de Seine) In addition to its head office, Ipsen has a significant presence in R&D (Paris-Saclay, Dreux and clinical trials across the country), three production and biproduction sites (Dreux, L'Isle-sur-la-Sorgue, Sig...
    The Ipsen group is an independent French pharmaceutical laboratory. Historically based on the Dreux (Eure) manufacturing site since 1929, the Ipsen group has its head office located in Boulogne-Billancourt (Hauts de Seine) In addition to its head office, Ipsen has a significant presence in R&D (Paris-Saclay, Dreux and clinical trials across the country), three production and biproduction sites (Dreux, L'Isle-sur-la-Sorgue, Signes) as well as promotional activities with health professionals in oncology, neurosciences, diseases rare and family health.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IpsenFrance Flag
    Country
    Country
    France
    Address
    Address
    65 Quai Georges Gorse, 92100 Boulogne-Billancourt
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ipsen.com/france/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ipsen/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ipsengroup

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Quotient Sciences Extends Mfg Partnership For Ultra-Rare Disease
    Quotient Sciences Extends Mfg Partnership For Ultra-Rare Disease

    27 Feb 2026

    // PRESS RELEASE

    https://www.quotientsciences.com/news/quotient-sciences-extends-commercial-manufacturing-partnership-ultra-rare-disease-treatment

    PRESS RELEASE
    27 Feb 2026
    Share Share
    Ipsen S.A. Publishes Its 2025 Consolidated Financial Statements
    Ipsen S.A. Publishes Its 2025 Consolidated Financial Statements

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3240829/0/en/Ipsen-S-A-publishes-its-2025-Consolidated-Financial-Statements.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Ipsen's Iqirvo Sales Hit $200M; GENFIT Gets $20M Milestone
    Ipsen's Iqirvo Sales Hit $200M; GENFIT Gets $20M Milestone

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237572/0/en/GENFIT-to-receive-US-20M-milestone-after-Ipsen-s-Iqirvo-exceeds-the-US-200M-threshold-in-its-first-full-year-of-net-sales.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Ipsen Reports Strong 2025 Results, Offers 2026 Guidance
    Ipsen Reports Strong 2025 Results, Offers 2026 Guidance

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3236839/0/en/Ipsen-delivers-strong-results-in-2025-driven-by-solid-execution-across-all-therapeutic-areas-and-provides-2026-guidance.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Ipsen Reports January 2026 Voting Rights And Share Capital
    Ipsen Reports January 2026 Voting Rights And Share Capital

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234804/0/en/Ipsen-January-2026-Monthly-information-relative-to-the-total-number-of-voting-rights-and-shares-composing-the-share-capital.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Origami Pharma Teams Up With Ipsen For Protein Degrader Program
    Origami Pharma Teams Up With Ipsen For Protein Degrader Program

    30 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260129525877/en/Origami-Therapeutics-Announces-Global-Collaboration-with-Ipsen-to-Advance-Protein-Degrader-Program

    BUSINESSWIRE
    30 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Ipsen and get a quotation

    Ipsen is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of Lanreotide Acetate bulk offered by Ipsen

    Find a price of DYSPORT (BOTULINUM TOXIN TYPE A-HEMAGGLUTININ COMPLEX) bulk offered by Ipsen

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search